Skip to main content
. 2021 Mar 10;3(4):234–240. doi: 10.1253/circrep.CR-21-0008

Figure 2.

Figure 2.

Changes in systolic (Upper panels) and diastolic (Lower panels) blood pressure in individual patients after the initiation of axitinib in all patients (A) and in patients who did not (B) or did (C) receive a tyrosine kinase inhibitor (TKI) as part of the first-line treatment regimen.